Schedule 13G filing

GLAZER CAPITAL, LLC disclosed a 5.5% stake in Biolife Solutions Inc (BLFS)

Schedule 13G · Filed Sep 24, 2026

GLAZER CAPITAL, LLC reported owning 5.5% of Biolife Solutions Inc (BLFS) (2,685,520 shares) in a Schedule 13G filed Sep 24, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Biolife Solutions Inc

Stake

5.5% stake

More BLFS insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.